Organicell Regenerative Medicine, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Organicell Regenerative Medicine, Inc. (OCEL) is 18.22M

According to Organicell Regenerative Medicine, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.22M. This represents a change of 58.96% compared to the average of 11.47M of the last 4 quarters.

Organicell Regenerative Medicine, Inc. (OCEL) Historical Enterprise Value (quarterly & annually)

How has OCEL Enterprise Value performed in the past?

The mean historical Enterprise Value of Organicell Regenerative Medicine, Inc. over the last ten years is 25.45M. The current 18.22M Enterprise Value has changed -28.38% with respect to the historical average. Over the past ten years (40 quarters), OCEL's Enterprise Value was at its highest in in the April 2021 quarter at 418.27M. The Enterprise Value was at its lowest in in the October 2017 quarter at 1.10M.

Organicell Regenerative Medicine, Inc. (OCEL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Organicell Regenerative Medicine, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Organicell Regenerative Medicine, Inc. (OCEL) Average Enterprise Value

How has OCEL Enterprise Value performed in the past?

The current Enterprise Value of Organicell Regenerative Medicine, Inc. (OCEL) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Organicell Regenerative Medicine, Inc. (OCEL) Enterprise Value vs. Peers

How is OCEL’s Enterprise Value compared to its peers?

Organicell Regenerative Medicine, Inc.’s Enterprise Value is less than Kadimastem Ltd (151.53M), greater than OptiBiotix Health Plc (4.80M), less than Rapid Dose Therapeutics Corp. (19.70M), less than OKYO Pharma Limited (60.45M), greater than Noxopharm Limited (15.03M), greater than Antisense Therapeutics Limited (817.70K), less than Sorrento Therapeutics, Inc. (111.04M), less than American Hemp Ventures, Inc. (0), greater than Valion Bio, Inc. (16.38M), greater than TPCO Holding Corp. (-8710833.00),

Build a custom stock screener for Organicell Regenerative Medicine, Inc. (OCEL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Organicell Regenerative Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Organicell Regenerative Medicine, Inc. (OCEL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Organicell Regenerative Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.